Nuveen Asset Management, LLC Biogen Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 321,308 shares of BIIB stock, worth $55.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

321,308

Previous 347,116 7.43%

Holding current value

$55.8 Million

Previous $74.8 Million 0.48%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$190.52 - $236.72 $4.92 Million - $6.11 Million	-25,808 Reduced 7.43%	321,308 $74.5 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $21.2 Million - $26.8 Million	-100,034 Reduced 22.37%	347,116 $74.8 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $30.2 Million - $36.3 Million	-135,603 Reduced 23.27%	447,150 $116 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $6.04 Million - $6.82 Million	-23,851 Reduced 3.93%	582,753 $150 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $97,989 - $113,229	-356 Reduced 0.06%	606,604 $173 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $14.1 Million - $16.1 Million	54,975 Added 9.96%	606,960 $169 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $5.23 Million - $6.35 Million	-20,703 Reduced 3.62%	551,985 $153 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $12.9 Million - $17.8 Million	66,300 Added 13.09%	572,688 $153 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $3.21 Million - $3.82 Million	-17,122 Reduced 3.27%	506,388 $103 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $8.85 Million - $11.1 Million	-45,656 Reduced 8.02%	523,510 $108 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $321,996 - $413,813	-1,438 Reduced 0.25%	569,166 $137 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $79 Million - $103 Million	-279,302 Reduced 32.86%	570,604 $161 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $5.85 Million - $9.37 Million	22,598 Added 2.73%	849,906 $294 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $18.5 Million - $21.6 Million	-76,002 Reduced 8.41%	827,308 $231 Million
Q4 2020 May 17, 2021	BUY	$236.26 - $355.63 $13.2 Million - $19.9 Million	56,009 Added 6.61%	903,310 $221 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $49.9 Million - $75.1 Million	211,105 Added 33.18%	847,301 $207 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $60.9 Million - $70.4 Million	-230,187 Reduced 26.57%	636,196 $180 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $37.5 Million - $49.7 Million	-145,063 Reduced 14.34%	866,383 $232 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $64.6 Million - $81.9 Million	-240,244 Reduced 19.19%	1,011,446 $320 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $9.52 Million - $13.2 Million	43,275 Added 3.58%	1,251,690 $371 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $24.1 Million - $27 Million	-110,665 Reduced 8.39%	1,208,415 $281 Million
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $242 Million - $266 Million	1,101,563 Added 506.43%	1,319,080 $308 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $17.6 Million - $27.5 Million	80,994 Added 59.33%	217,517 $51.4 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $17.1 Million - $21.7 Million	61,473 Added 81.91%	136,523 $41.1 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $2.81 Million - $3.68 Million	9,580 Added 14.63%	75,050 $26.5 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $21.2 Million - $25.3 Million	-82,338 Reduced 55.71%	65,470 $19 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $2.03 Million - $2.87 Million	-7,813 Reduced 5.02%	147,808 $40.5 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $5.92 Million - $6.63 Million	19,239 Added 14.11%	155,621 $0
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $38.3 Million - $45 Million	136,382	136,382 $42.7 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Biogen Inc. Transaction History